Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cx9C motif-containing protein 4 (CMC4) is a small cysteine-rich mitochondrial protein characterized by the presence of a distinctive twin CX9C motif—a conserved pattern of cysteine residues spaced by nine amino acids that is implicated in the stabilization of a coiled-coil structure[2][3]. CMC4 localizes to the mitochondrial inner membrane, facing the intermembrane space, where it is involved in the correct assembly of cytochrome c oxidase (COX), a crucial component of the mitochondrial electron transport chain[1][6]. By binding copper(I) ions, CMC4 is thought to play an important role in copper trafficking and homeostasis within mitochondria, impacting both COX activity and other mitochondrial enzymes such as superoxide dismutase (SOD1)[1]. In humans, the gene is designated CMC4 (HGNC symbol: 35428; UniProt: P56277) and has been implicated in complex chromosomal rearrangements associated with certain hematologic malignancies, notably mature T-cell proliferations involving t(X;14) translocations[4]. Although not established as a therapeutic drug target, alterations or mutations in CMC4 have associations with diseases such as Moyamoya disease 1 and Rhabdomyolysis-myalgia syndrome[4]. At present, no drugs are known to interact specifically with this protein, and established clinical biomarkers or direct safety concerns are not documented in the literature[6][4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cx9C motif-containing protein 4 (CMC4).